Skip to content

Technology

Genome-scale models meet hybrid AI

A five-stage pipeline rooted in a decade of systems biotechnology at NOVA University Lisbon — validated on CHO, HEK, and other mammalian platforms.

The pipeline

From public genomes to optimized formulations — with a fraction of the experiments traditional screening requires.

  1. 1

    Genome & annotation

    Curate genomic data for your cell line — most industrially relevant lines already have sequenced genomes and public models.

  2. 2

    Genome-scale model

    Build or adapt a GEM: metabolites, reactions, and transport tailored to your medium and cell line.

  3. 3

    Designed experiments

    A targeted design of experiment yields the exchange fluxes and omics readouts needed to train hybrid models — not exhaustive screening.

  4. 4

    Hybrid semi-parametric AI

    Blend mechanistic FBA with data-driven constraints (PCA / ML) so predictions respect both biology and your process data.

  5. 5

    Optimize & deliver

    Multi-objective optimization proposes media, feed composition, and feeding strategy — then we validate in the lab.

At a glance

Mechanistic models + machine learning

Genome-scale metabolic networks provide scientific structure. Hybrid semi-parametric models learn from your data. Optimization searches the space of media and feeds for your objectives.

Mechanistic

GEM stoichiometry, mass balance, pathway constraints

Data-driven

PCA / ML constraints from targeted experiments

Optimization

Multi-objective media, feeds & feeding strategy

Research foundation

Published science behind the platform

Levacells builds on peer-reviewed work by Rui Oliveira’s group at LAQV REQUIMTE (NOVA University Lisbon) and João Ramos’s hybrid genome-scale modelling — including culture media design, dynamic cell models, and functional enviromics.

Ready to optimize your cell culture?

Tell us about your cell line and process goals — we will explore whether our approach fits your timeline.